M.B.A., Chief Strategy Officer, miR Scientific
Biography
Tal is a seasoned impact investment professional with broad transaction experience that spans industries, sectors and geographies. His roots in the sustainability and healthcare sectors run deep, with corporate leadership roles and prominent presence as investor, advisor and board member in companies and investment funds. As Chief Strategy Officer of miR Scientific, Tal draws on his extensive experience in structuring transactions to craft, articulate and execute strategic dialogues and commercialization initiatives for miR. Tal received his M.B.A. with distinction from New York University’s Stern School of Business and his B.A. degree magna cum laude in Economics from Queens College.
Clinical Dx Showcase:
miR Scientific
miR Scientific (www.mirscientific.com) is a precision bioscience company that has developed proprietary, non-invasive liquid biopsy urine tests that definitively detect, accurately score and continuously monitor prostate and bladder cancers.
